entertainment -WSS

entertainment

author：knowledge 2025-10-01 20:14:03 - browse：5984

Hyacinth Empinado/STAT

The body mass index, or BMI, is the formula that’s used most often to diagnose overweight and obesity. But unlike other common diagnoses, there is a certain stigma applied to people with a high body mass index, or BMI, which can affect how they are perceived by peers, providers, and society at large.

Despite the ubiquity of the BMI in medicine, many argue that it is a flawed tool, with a strange history. In recent months, the BMI has become more relevant than ever as the new semaglutide weight loss drugs are poised to change how obesity is understood and treated.

BMI is a simple calculation — a person’s weight in kilograms divided by the square of their height. But how BMI is then translated into a diagnosis is complicated and flawed.

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

Watch this video to learn more about the history of the BMI — how it became so entrenched in medicine and, surprisingly, how its introduction may have set back decades of work on how obesity contributes to disease.

A STAT series is examining new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution.

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： The most pressing bird flu mysteries scientists want answered

Wikipedia

WSS

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

BD to buy Edwards patient monitoring unit for $4.2 billion

Childhood cancer progress stalls for Black, Hispanic kids: Report

Fight over Supreme Court dialysis ruling puts kidney patients at risk

NYU radiologists take on the challenge of expensive MRI machines

hotspot

entertainment

Related: New weight loss drugs are changing the narrative on obesity, with a push from pharma

focus

Cancer drug shortages should be causing more outrage

Sutter Health’s antitrust win overturned by appeals court

Medical records are filled with copy

A new initiative will help leaders fight the next pandemic

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Trump demands the U.S. pay no more for drugs than other countries … again

CMS got Medicare Advantage quality rating wrong, judge rules

United colonoscopy coverage change 'may cost lives,' doctors say

World's first CRISPR

hotspot

Congress must reauthorize a committee to support older Americans

Fight over Supreme Court dialysis ruling puts kidney patients at risk

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

A daunting task: navigating dual Medicare, Medicaid eligibility

Congress must reauthorize a committee to support older Americans

Morphosys mixed study results for blood cancer drug

knowledge

Wikipedia

Wikipedia

explore